. Author manuscript; available in PMC: 2014 Dec 19.

Published in final edited form as: Neuroscience. 2013 Sep 19;254:10.1016/j.neuroscience.2013.09.025. doi: 10.1016/j.neuroscience.2013.09.025

Table 3.

Pharmacological effects on Tc (°C) and DSI activity (median, inter-quartile range) during the 30 min interval prior to daily dark onset (ZT11.5-ZT12).

	Tc	Activity
VEH	36.81 (36.56/37.11)^a	5.5 (2.7/8.3)^b
MOD	37.57 (37.19/37.78)^a	45.5 (30.5/57.2)^b
VEH	36.86 (36.65/37.09)^c	6.4 (3.9/9.5)^d
MA	36.61 (36.24/36.86)^c	75.4 (57.4/88.3)^d
VEH*	36.8 (36.4/37.0)^e	4.2 (1.5/5.8)^f
CAF 20mg	37.6 (37.5/37.7)^e	19.2 (16.2/23.1)^f
CAF 40mg	37.1 (36.7/37.3)^e	32.9 (25.2/41.7)^f

Differ

p=.007

p<.001, Mann-Whitney tests

p=.018

p<.001, Mann-Whitney tests

Differ p<.05, SNK tests after significant Kruskal-Wallis ANOVA.